Guan Liu
38 Guangji Road
Hangzhou, 310022, China
Hangzhou, 310022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
LncRNA PVT1 promotes proliferation and migration in gallbladder adenocarcinoma by modulating miR-2355-5p/AGO1 axis.
Journal: In vitro cellular & developmental biology. Animal
Published: December 01, 2024
In vitro and in vivo superior radiosensitizing effect of berbamine for head and neck squamous cell carcinoma.
Journal: OncoTargets and therapy
Published: December 12, 2018
Combined nimotuzumab with chemoradiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma: A retrospective study.
Journal: Journal of cancer research and therapeutics
Published: October 11, 2016
The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.
Journal: Journal of cancer research and therapeutics
Published: October 11, 2016
Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer.
Journal: Molecular and clinical oncology
Published: May 27, 2015
Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 09, 2015
CDK2-AP1 inhibits growth of breast cancer cells by regulating cell cycle and increasing docetaxel sensitivity in vivo and in vitro.
Journal: Cancer cell international
Published: March 11, 2014
A new receptor tyrosine kinase inhibitor, icotinib, for patients with lung adenocarcinoma cancer without indication for chemotherapy.
Journal: Oncology letters
Published: November 17, 2013
Positive expression of p53, c-erbB2 and MRP proteins is correlated with survival rates of NSCLC patients.
Journal: Molecular and clinical oncology
Published: July 20, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026